6952
B.H. Lipshutz et al. / Tetrahedron 64 (2008) 6949–6954
7.70 mmol), and di-(4-chlorobenzyl)azodicarboxylate (2.95 g,
8.05 mmol). Column chromatography (eluting with 5% EtOAc/
hexanes) afforded the product as a yellow liquid (1.28 g, 88%); IR
(neat): 3081, 2939, 1651, 1595, 1518, 1471, 1377, 1347, 1299, 1260,
3033, 2959, 2930, 2860, 1719, 1659, 1606, 1593, 1514, 1495, 1455,
1380,1342,1253,1198,1171,1112,1021, 978, 875, 847 cmꢁ1; 1H NMR
(400 MHz, CDCl3):
d
8.20 (d, J¼9.2 Hz, 2H), 7.00 (dt, J¼15.6, 6.8 Hz,
1H), 6.95 (d, J¼9.2 Hz, 2H), 5.98 (d, J¼15.6 Hz, 1H), 4.17 (t, J¼6.4 Hz,
2H), 4.07 (dd, J¼10.8, 5.6 Hz,1H), 4.04 (dd, J¼10.8, 6.0 Hz,1H), 2.76–
2.71 (m, 2H), 1.63–1.59 (m, 1H), 1.38–1.28 (m, 8H), 0.91–0.88 (m,
1173, 1111, 1039, 1012, 896, 846 cmꢁ1 1H NMR (400 MHz, CDCl3):
;
d
8.20 (d, J¼9.2 Hz, 2H), 6.96 (d, J¼9.2 Hz, 2H), 4.88 (d, J¼1.2 Hz,1H),
4.81 (d, J¼1.2 Hz, 1H), 4.18 (t, J¼6.8 Hz, 2H), 2.55 (t, J¼6.8 Hz, 2H),
1.82 (s, 3H); 13C NMR (100 MHz, CDCl3):
164.2, 142.0, 126.1, 114.6,
6H); 13C NMR (100 MHz, CDCl3):
d
166.6, 163.7, 143.6, 141.8, 126.1,
d
124.2, 114.6, 67.1, 66.9, 38.9, 31.9, 30.6, 29.1, 24.0, 23.1, 14.2, 11.2; MS
112.7, 67.4, 37.0, 22.9; MS (EI) m/z (%): 207 (M, 7), 179 (5), 152 (4), 69
(100); HRMS (EI) calcd for C11H13NO3 [M]þ¼207.0895, found
207.0903.
(ESI): m/z 372 (MþNa); HRMS (ESI) calcd for
[MþNa]þ¼372.1787, found 372.1792.
C19H27NO5Na
4.5.4. (E)-6-(4-Nitrophenoxy)hex-3-en-2-one (6d)
4.5. General procedure for cross-metathesis
From olefin 1 (97 mg, 0.50 mmol) following the general pro-
cedure using methylvinyl ketone (122 L,1.50 mmol), and catalyst 3
m
The general procedure is illustrated by the preparation of
dienone 9e. To a solution of olefin 8 (135 mg, 0.50 mmol) and ethyl
vinyl ketone (149 mL, 1.5 mmol) in CH2Cl2 (2.5 mL) was added 3
(6.3 mg, 0.01 mmol, 2.0 mol %), and the mixture was refluxed for
15 h. The flask was fitted with a condenser and refluxed under ar-
gon for 15 h. The reaction mixture was then reduced in volume to
0.5 mL and purified directly on a silica gel column, eluting with 6:1
hexanes–ethyl acetate to provide 9e (158 mg, 97%) as a pale yellow
liquid. IR (neat): 3085, 3033, 2978, 2938, 1699, 1674, 1632, 1592,
(6.3 mg, 0.01 mmol), elution with 4:1 hexanes–ethyl acetate affor-
ded 6d (108 mg, 92%) as a white solid. Mp¼56–57 ꢀC; IR (thin film):
3079, 3023, 2952, 1699, 1678, 1631, 1594, 1501, 1426, 1337, 1271,
1210, 1179, 1112, 1020, 990, 858, 818 cmꢁ1 1H NMR (400 MHz,
;
CDCl3):
d
8.23 (d, J¼9.2 Hz, 2H), 6.98 (d, J¼9.2 Hz, 2H), 6.87 (dt,
J¼16.0, 6.8 Hz, 1H), 6.23 (dt, J¼16.0, 1.6 Hz, 1H), 4.20 (t, J¼6.4 Hz,
2H), 2.78 (qd, J¼6.0, 1.2 Hz, 2H), 2.29 (s, 3H); 13C NMR (100 MHz,
CDCl3): d 198.4,163.7,142.8,141.8,133.5,126.1,114.6, 66.8, 32.1, 27.3;
MS (ESI): m/z 258 (MþNa), 236 (MþH); HRMS (ESI) calcd for
1510, 1455, 1419, 1342, 1253, 1200, 1173, 1112, 979, 917, 847 cmꢁ1
1H NMR (400 MHz, CDCl3):
;
C
12H13NO4Na [MþNa]þ¼258.0742, found 258.0738.
d
8.07 (d, J¼9.2 Hz, 2H), 7.38–7.27 (m,
5H), 6.89 (d, J¼9.2 Hz, 2H), 6.83 (dt, J¼16.0, 7.2 Hz, 1H), 6.17 (d,
J¼16.0 Hz, 1H), 5.34 (dd, J¼7.6, 4.8 Hz, 1H), 2.97–2.89 (m, 1H), 2.83–
2.76 (m, 1H), 2.54 (q, J¼7.2 Hz, 2H), 1.07 (t, J¼7.2 Hz, 3H); 13C NMR
4.5.5. (E)-7-(4-Nitrophenoxy)hept-4-en-3-one (6e)
From olefin 1 (97 mg, 0.50 mmol) following the general pro-
cedure using ethyl vinyl ketone (150 mL, 1.50 mmol) and catalyst 3
(100 MHz, CDCl3):
d
200.8, 162.8, 141.7, 140.6, 139.3, 132.9, 129.2,
(6.3 mg, 0.01 mmol), elution with 4:1 hexanes–ethyl acetate,
afforded 6e (119 mg, 95%) as a white solid. Mp¼44–46 ꢀC; IR (thin
film): 3086, 2977, 2938, 1698, 1673, 1633, 1607, 1593, 1512, 1469,
128.7, 125.9, 125.8, 115.9, 79.7, 41.4, 33.7, 8.1; MS (ESI): m/z 364
(MþK), 348 (MþNa), 326 (MþH); HRMS (ESI) calcd for
C
19H19NO4Na [MþNa]þ¼348.1212, found 348.1209.
1341, 1299, 1262, 1174, 1111, 1025, 978, 847 cmꢁ1 1H NMR
;
(400 MHz, CDCl3):
d
8.22 (d, J¼9.2 Hz, 2H), 6.96 (d, J¼9.2 Hz, 2H),
4.5.1. (E)-tert-Butyl 5-(4-nitrophenoxy)pent-2-enoate (6a)
6.89 (dt, J¼16.0, 7.2 Hz, 1H), 6.26 (dt, J¼16.0, 1.2 Hz, 1H), 4.19 (t,
J¼6.4 Hz, 2H), 2.76 (qd, J¼6.4, 1.2 Hz, 2H), 2.61 (q, J¼7.2 Hz, 2H), 1.12
From olefin 1 (97 mg, 0.50 mmol) following the general pro-
cedure using tert-butyl acrylate (146
m
L, 1.0 mmol) and catalyst 3
(t, J¼7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3):
d 200.9, 163.7, 141.8,
(6.3 mg, 0.01 mmol), elution with 19:1 hexanes–ethyl acetate,
afforded 6a (141 mg, 96%) as a colorless liquid. IR (neat): 3115, 3087,
2979, 2934, 1709, 1656, 1595, 1509, 1473, 1391, 1367, 1340, 1265,
141.4, 132.3, 126.1, 114.6, 66.9, 33.7, 32.1, 8.1; MS (CI) m/z (%): 250
(MþH, 15), 178 (11), 140 (55), 111 (100); HRMS (CI) calcd for
C
13H16NO4 [MþH]þ¼250.1079, found 250.1083.
1173, 1111, 1029, 981, 848 cmꢁ1 1H NMR (400 MHz, CDCl3):
; d 8.21
(d, J¼9.2 Hz, 2H), 6.96 (d, J¼9.2 Hz, 2H), 6.91 (dt, J¼15.6, 6.8 Hz, 1H),
4.5.6. (E)-tert-Butyl 5-(4-nitrophenoxy)-5-phenylpent-
2-enoate (9a)
5.90 (d, J¼15.6 Hz, 1H), 4.17 (t, J¼6.4 Hz, 2H), 2.72 (qd, J¼6.8, 1.6 Hz,
2H), 1.50 (s, 9H); 13C NMR (100 MHz, CDCl3):
d
165.7, 163.8, 142.4,
From olefin 8 (135 mg, 0.50 mmol) following the general pro-
141.8, 126.1, 125.8, 114.6, 80.7, 67.0, 31.7, 28.3; MS (ESI): m/z 316
cedure using tert-butyl acrylate (146 mL, 1.00 mmol) and catalyst 3
(MþNa), 294 (MþH); HRMS (ESI) calcd for
C
15H19NO5Na
(6.3 mg, 0.01 mmol), elution with 19:1 hexanes–ethyl acetate,
afforded 9a (172 mg, 93%) as a colorless liquid. IR (neat): 3063,
2979, 2932, 1711, 1656, 1593, 1513, 1495, 1455, 1422, 1391, 1367,
1342, 1253, 1152, 1112,1009, 981, 917, 847 cmꢁ1; 1H NMR (400 MHz,
[MþNa]þ¼316.1161, found 316.1161.
4.5.2. (E)-Methyl 5-(4-nitrophenoxy)pent-2-enoate (6b)
From olefin 1 (124 mg, 0.64 mmol) following the general pro-
cedure using methyl acrylate (173 L, 1.92 mmol) and catalyst 3
CDCl3):
d
8.08 (d, J¼9.2 Hz, 2H), 7.38–7.28 (m, 5H), 6.91–6.85 (m,
m
3H), 5.85 (d, J¼15.6 Hz, 1H), 5.31 (dd, J¼7.6, 4.8 Hz, 1H), 2.94–2.86
(8.0 mg, 0.013 mmol), elution with 9:1 hexanes–ethyl acetate,
afforded 6b (143 mg, 89%) as a white solid. Mp¼41–43 ꢀC; IR (thin
film): 3114, 3086, 2951, 1722, 1660, 1607, 1594, 1512, 1469, 1437,
(m, 1H), 2.78–2.73 (m, 1H), 1.47 (s, 9H); 13C NMR (100 MHz, CDCl3):
d
165.7, 162.9, 142.0, 141.7, 139.5, 129.2, 128.6, 126.3, 125.9, 116.0,
80.7, 79.7, 41.1, 28.3; MS (ESI): m/z 408 (MþK), 392 (MþNa), 370
(MþH); HRMS (ESI) calcd for C21H23NO5Na [MþNa]þ¼392.1474,
found 392.1467.
1342, 1299, 1262, 1219, 1173, 1111, 1031, 978, 847 cmꢁ1 1H NMR
;
(400 MHz, CDCl3):
d
8.22 (d, J¼9.2 Hz, 2H), 7.04 (dt, J¼16.0, 6.8 Hz,
1H), 6.96 (d, J¼9.2 Hz, 2H), 6.00 (dt, J¼16.0, 1.2 Hz, 1H), 4.18 (t,
J¼6.4 Hz, 2H), 3.76 (s, 3H), 2.75 (qd, J¼6.4, 1.2 Hz, 2H); 13C NMR
4.5.7. (E)-Methyl 5-(4-nitrophenoxy)-5-phenylpent-2-enoate (9b)
From olefin 8 (108 mg, 0.40 mmol) following the general pro-
(100 MHz, CDCl3):
d 166.8, 163.7, 144.2, 141.9, 126.1, 123.7, 114.6,
66.8, 51.8, 31.9; MS (ESI): m/z 274 (MþNa), 252 (MþH); HRMS (ESI)
cedure using methyl acrylate (108 mL, 1.20 mmol) and catalyst 3
calcd for C12H13NO5Na [MþNa]þ¼274.0691, found 274.0696.
(5.0 mg, 0.008 mmol), elution with 7:1 hexanes–ethyl acetate,
afforded 9b (122 mg, 93%) as a pale yellow liquid. IR (neat): 3084,
3031, 2951, 2844, 1721, 1660, 1593, 1513, 1495, 1454, 1436, 1342,
4.5.3. (E)-2-Ethylhexyl 5-(4-nitrophenoxy)pent-2-enoate (6c)
From olefin 1 (97 mg, 0.50 mmol) following the general pro-
1251, 1201, 1172, 1112, 1023, 979, 917, 862, 847 cmꢁ1 1H NMR
;
cedure using O-2-ethylhexyl acrylate (209
mL, 1.0 mmol) and cata-
(400 MHz, CDCl3): d 8.10–8.06 (m, 2H), 7.37–7.29 (m, 5H), 6.99 (dt,
lyst 3 (6.3 mg, 0.01 mmol), elution with 11:1 hexanes–ethyl acetate,
afforded 6c (163 mg, 93%) as a pale yellow liquid. IR (neat): 3064,
J¼15.6, 7.2 Hz, 1H), 6.91–6.87 (m, 2H), 5.92 (d, J¼15.6 Hz, 1H), 5.34
(dd, J¼7.2, 4.4 Hz, 1H), 3.71 (s, 3H), 2.96–2.89 (m, 1H), 2.82–2.76 (m,